| Website | aragonpharmaceuti... |
| Category | BioTech |
| Employees | |
| Description | Hormone-resistant Cancer Treatment |
| Series A, 5/09 The Column Group OrbiMed Advisors | $8M |
Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.